Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine

Vaccine

Volumn 29, Issue 4, 2011, Pages 617-623

  Chao, Day Yu ^a   Cheng, Kuang Fu ^b   Hsieh, Ying Hen ^b   Li, Tsai Chung ^b   Wu, Trong Neng ^b   Chen, Chiu Ying ^b   Tsai, Chen An ^b   Chen, Jin Hwa ^b   Chiu, Hsien Tsai ^b   Lu, Jang Jih ^b,c   Su, Mei Chi ^c   Liao, Yu Hsin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2009 pH1N1; Immune response; Pandemic influenza; Schoolchildren; Serology; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; VACCINATION;

ANTIBODIES, VIRAL; CHILD; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANDEMICS; TIME FACTORS;

EID: 78650563942     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.016     Document Type: Article

References (28)

1. Garten R., Davis C., Russell C., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
2. Perez-Padilla R., Rosa-Zamboni D.dl., Leon S.Pd., Hernandez M., Quiñones-Falconi F., Bautista E., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361(7):680-689.
3. Novel Swin-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360:2605-2615.
4. Maines T., Jayaraman A., Belser J., Wadford D., Pappas C., Zeng H., et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009, 325(5939):484-487.
5. Hancock K., Veguilla V., Lu X., Zhong W., Butler E., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952.
6. Nichol K.L. Efficacy and effectiveness of influenza vaccination. Vaccine 2008, 26(Suppl. 4):D17-D22.
7. Jordan R., Connock M., Albon E., Fry-Smith A., Olowokure B., Hawker J., et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006, 24(8):1047-1062.
8. Reichert T., Sugaya N., Fedson D., Glezen W., Simonsen L., Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001, 344(12):889-896.
9. Poehling K., Talbot H., Williams J., Zhu Y., Lott J., Patterson L., et al. Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties. Vaccine 2009, 27(20):2695-2700.
10. Basta N., Chao D., Halloran M., Matrajt L., Longini I.J. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol 2009, 170(6):679-686.
11. Yang Y., Sugimoto J., Halloran M., Basta N., Chao D., Matrajt L., et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009, 326(5953):729-733.
12. Medlock J., Galvani A. Optimizing influenza vaccine distribution. Science 2009, 325(5948):1705-1708.
13. Vajo Z., Tamas F., Sinka L., Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010, 375:49-55.
14. Greenberg M., Lai M., Hartel G., Wichems C., Gittleson C., Bennet J., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361(25):2405-2413.
15. Zhu F., Wang H., Fang H., Yang J., Lin X., Liang X., et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009, 361(25):2414-2423.
16. Liang X., Wang H., Wang J., Fang H., Wu J., Zhu F., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010, 375(9708):56-66.
17. Nolan T., McVernon J., Skeljo M., Richmond P., Wadia U., Lambert S., et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010, 303(1):37-46.
18. Waddington C., Walker W., Oeser C., Reiner A., John T., Wilkins S., et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ 2010, 340:c2649.
19. Lu C., Shao P., Chang L., Huang Y., Chiu C., Hsieh Y., et al. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents. Vaccine 2010, 28(36):5864-5870.
20. Kao T., Hsieh S., Kung H., Lee Y., Huang K., Huang L., et al. Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly. Vaccine 2010, 28(38):6159-6163.
21. Fiore A., Shay D., Broder K., Iskander J., Uyeki T., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(RR-8):1-52.
22. Rowe T., Abernathy R., Hu-Primmer J., Thompson W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37(4):937-943.
23. Kung H., Huang K., Kao T., Lee Y., Chang F., Wang N., et al. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza. Vaccine 2010, Sep 15 [Epub ahead of print].
24. Clark T., Pareek M., Hoschler K., Dillon H., Nicholson K., Groth N., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009, 361(25):2424-2435.
25. Nolan T., Richmond P., Formica N., Höschler K., Skeljo M., Stoney T., et al. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 2008, 26(50):6383-6391.
26. Peacey M., Sonnberg S., Ducatez M., Paine S., Nicol M., Ralston J., et al. Pandemic (H1N1) 2009 and seasonal A (H1N1) influenza co-infection, New Zealand, 2009. Emerg Infect Dis 2010, 16(10):1618-1620.
27. Cohen J. Vaccine policy. Immunizing kids against flu may prevent deaths among the elderly. Science 2004, 306(5699):1123.
28. Bishop J.F., Murnane M.P., Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med 2009, 361(27):2591-2594.